ロード中...
Mercaptopurine/Methotrexate Maintenance Therapy of Childhood Acute Lymphoblastic Leukemia: Clinical Facts and Fiction
The antileukemic mechanisms of 6-mercaptopurine (6MP) and methotrexate (MTX) maintenance therapy are poorly understood, but the benefits of several years of myelosuppressive maintenance therapy for acute lymphoblastic leukemia are well proven. Currently, there is no international consensus on drug d...
保存先:
| 出版年: | J Pediatr Hematol Oncol |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Lippincott Williams & Wilkins
2014
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4222610/ https://ncbi.nlm.nih.gov/pubmed/24936744 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MPH.0000000000000206 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|